Amarin Corp. (AMRN) gains 6.3% as major shareholders push for a strategic review to recover value after a dramatic stock drop ...

Bradley Radoff and Michael Torok, the Managing Director of JEC Capital Partners, who collectively own approximately 15M shares of Amarin ...

the “Concerned Shareholder Group” or “we”), who collectively own approximately 15 million shares of Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”), today issued ...

Amarin Corporation announced the presentation of new in vitro data on eicosapentaenoic acid (EPA) at the American College of Cardiology's Annual Scientific Session & Expo from March 29-31 ...

Despite exceeding Street forecasts with its Q4 2024 financials, Amarin Corporation (NASDAQ:AMRN) traded lower in the ...

Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...

Corporation announced that additional in vitro mechanistic data with eicosapentaenoic acid, EPA, will be presented at the ...

Radoff and Michael Torok of JEC Capital Partners, along with affiliates known as the Concerned Shareholder Group, who collectively own about 15 million shares of Amarin Corporation plc (NASDAQ ...

Amarin Corp PLC (AMRN) reports strong international growth and strategic advancements despite US market pressures.

While we appreciate Sarissa Capital Management's ("Sarissa") involvement and commitment to the Company, we believe shareholders would be best served by the Board immediately conducting a strategic ...

Welcome to Amarin Corporation's Conference Call to discuss its Fourth Quarter and Full Year 2024 Business Update and Financial Results. I would like to turn the conference call over to Mark Marmur ...

Welcome to Amarin Corporation's conference call to discuss its fourth-quarter and full-year 2024 business update and financial results. I would like to turn the conference call over to Mark Marmur ...